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Abstract
Cowpox virus (CPXV) is described as the source of the first vaccine used to prevent the onset and spread of an infectious
disease. It is one of the earliest described members of the genus Orthopoxvirus, which includes the viruses that cause
smallpox and monkeypox in humans. Both the historic and current literature describe ‘‘cowpox’’ as a disease with a single
etiologic agent. Genotypic data presented herein indicate that CPXV is not a single species, but a composite of several (up
to 5) species that can infect cows, humans, and other animals. The practice of naming agents after the host in which the
resultant disease manifests obfuscates the true taxonomic relationships of ‘‘cowpox’’ isolates. These data support the
elevation of as many as four new species within the traditional ‘‘cowpox’’ group and suggest that both wild and modern
vaccine strains of Vaccinia virus are most closely related to CPXV of continental Europe rather than the United Kingdom, the
homeland of the vaccine.
Citation: Carroll DS, Emerson GL, Li Y, Sammons S, Olson V, et al. (2011) Chasing Jenner’s Vaccine: Revisiting Cowpox Virus Classification. PLoS ONE 6(8): e23086.
doi:10.1371/journal.pone.0023086
Editor: Yan Xiang, Univ. of Texas HSC at San Antonio, United States of America
Received June 3, 2011; Accepted July 5, 2011; Published August 8, 2011
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for
any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Funding: The authors have no support or funding to report.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: DCarroll@cdc.gov
Introduction
Cowpox virus (CPXV) is one of the earliest described members of
the genus Orthopoxvirus (OPV). Historically, researchers referred to
the ailment known as cowpox and even suggested that it could
provide immunity against smallpox [1]. However it was Jenner’s
publications in 1798 and 1799 which provided the first scientific
description of vaccination by detailing the efficacy of CPXV
‘‘scarification’’ in inducing protective immunity against challenge
with variola virus (VARV) [2,3]. The common name ‘‘cowpox
virus’’ refers to the association with pustular lesions on the teats of
milking cows and historic zoonotic transmission of this disease to
humans (milkers) through contact with infected cows. Human
infections are generally mild and self-limiting with localized skin
lesions healing after 3–4 weeks, however, systemic involvement
and fatal outcome have been reported in immunocompromised
individuals [4,5].
CPXV is believed to be endemic to Eurasia, but cowpox-like
illness has also been reported in Israel [6]. The last few decades
have witnessed an increasing number of reports of human CPXV
infection in Europe, as well as the infection of a broad range of
domestic and zoological garden animals including; elephants,
primates, cats, and pet rodents. Cowpox in cats was first described
by Thomsett in 1978 [7]. The first zoonotic transmission of CPXV
from cat to human was documented in 1985 from the Nether-
lands. CPXV genomes isolated from cats in England are closely
related to those obtained from cows and their handlers in the same
region [8,9]. In addition, more than 30 outbreaks have been
described in zoo animals between 1960 and 2010. Long-term
ecological studies on CPXV indicate that, although the virus rarely
has been isolated from them, wild rodents are the likely reservoir
hosts of CPXV and infection rates vary seasonally [10,11,12].
Recent human cases have been primarily associated either with
contact with pet rats or contact with infected cats (presumably
infected by wild rodents), and not from contact with infected
cattle.
Among Orthopoxvirus species, traditionally defined CPXV have
the largest genomes averaging above 220 kbp, about 30 kbp larger
than the average known Vaccinia virus (VACV) genome. Only the
genome from Horsepox virus, a presumed ‘‘wild’’ VACV isolate, is
larger than 200 kb (212633 bases). But like other OPVs roughly
30–40% of the CPXV genome encodes products that play
important roles in virus pathogenesis and host range. Several
CPXV open reading frames (ORFs) have nucleotide sequence
similarity to immunomodulatory and host range function genes,
while others interfere with host activation cascades [13].
Phenotypic features differentiating currently recognized CPXV
from other OPV species are the presence of large eosinophilic A-
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4 mm flattened, fairly rounded pocks with a red central
hemorrhagic area on the chorioallantoic membrane (CAM) of
embryonated eggs at 72 hours post inoculation; and large,
indurated, hemorrhagic lesions on scarified rabbit skin. Restriction
fragment length polymorphisms (RFLP) generated with HindIII,
and to lesser extent BamHI, XhoI and/or SmaI, and construction of
physical genome maps, have been used to differentiate between
CPXV strains. These methodologies revealed higher genotypic
variation in German CPXV isolates than those from Scandinavia
and the UK, which suggests the potential for geographically
independent evolution of these viruses and perhaps differences in
their rodent reservoir species [14].
Previous phylogenetic studies comprised of fewer viral isolates
and based on more limited sets of proteins or nucleotide sequences
from single genes have reported a ‘‘remarkable divergence’’
between CPXV strains, specifically CPXV Brighton Red and
CPXV Grishak, and have suggested these two isolates could
represent different species [15,16]. In this study we include both a
wider range of isolates and present phylogenetic and genomic
analyses based on the whole genome from nine CPXV strains
circulating in Europe as well as three genomes of CPXV from
Great Britain, Moscow and Germany, sequenced previously
(Brighton Red, GRI-90, GER 1991-3). This more expanded
taxonomic and genotypic data set clearly suggests CPXV, as
currently recognized, is a polyphyletic assemblage. Therefore the
current CPXV taxonomic rank must be divided into multiple
species which each represent a monophyletic lineage.
Materials and Methods
Whole genome (nucleotide) sequences from 12 isolates identified
as CPXV were utilized in this study. The locations and details
relevant to these isolates are listed in Table 1. Three fully
sequenced CPXV strains were obtained from GenBank: CPXV
strain Brighton Red (CPXV BR; 224,499 bp, 235 ORFs,
GenBank No: AF482758) originating from the hand of a milker
in Great Britain in 1938; strain GRI-90 (223,666 bp, 214 ORFs,
GenBank No: X94355) isolated in 1990 from a 4 year old girl in
Moscow that had contact with a mole and CPXV strain OPV
GER 1991-3 (228,250 bp, 219 ORFs, GenBank No: DQ 437593)
isolated in 1991 from a human case in Germany. Whole genome
sequences from nine of these isolates were generated for this study
using Sanger sequencing methodologies as previously described
[17]. These sequences were deposited in GenBank and accession
numbers can be found in Table 1. MAFFT [18] was used to align
the OPV coding region (VACV C23L-B29R) for the twelve
CPXV isolates with the following additional genome sequences:
Variola virus (L22579, Y16780), Taterapox virus (NC_008291),
Camelpox virus (CMLV) (AY009089, NC_003391), Monkeypox virus
(MPXV) (DQ011156, DQ011155), four vaccine (Vaccinia virus)
strains (AY678276, M35027, AM501482, DQ377945) as well as
three non-vaccine VACV strains including one strain from a
buffalo from India, one from a horse in Mongolia (DQ792504),
and one laboratory-obtained, Rabbitpox virus Utrect isolate
(AY484669). Two Ectromelia virus isolates (NC_004105, see www.
poxvirus.org for Ectromelia virus strain Naval) were included as
outgroup taxa. After the complete alignment was obtained, all
gapped columns were excluded leaving a datset with a length of
145204 bp.
Phylogenetic analyses were conducted using MrBayes with the
following settings: nst=6, rates=invgamma, mcmc, 2 M gener-
ations, samplefreq=1000, nchains=4 and burnin=1000. PAUP*
[19] was used to calculate pairwise genetic distances (uncorrected
p) for comparisons between taxa. Patristic distances (tree branch
lengths between taxa) between isolates were calculated from the
Table 1. CPXV isolates.
Strain Place of isolation Year Clinical description Host Reference Accession #
CPXV_gri Russia, Moscow 1990 Local lesions human Marennikova et al. 1996
Zh Mikrobiol 4:6–10
X 94355
CPXV_BR United Kingdom, Brighton 1937 Local lesions human Downie 1939 British Journal of
Experimental Pathology 2o:I58–176
NC 003663
CPXV_GER1991_3 Germany, Munich 1991 Local lesions human Meyer et al. 1999 Arch
Virol 144:491–501
DQ 437593
CPXV_FIN2000_MAN Finland, Tohmaja ¨rvi 2000 Generalized lesions human Pelkonen et al. 2003 EID 9:1458–61 HQ420893
CPXV_NOR1994_MAN Norway, Bergen 1994 Local lesions human Tryland et al. 1998 Scand
J Infect Dis 30:301–303
HQ420899
CPXV_GER1990_2 Germany, Bonn 1990 Fatal generalization human Eis-Hu ¨binger et al.
1990 Lancet 336:880
HQ420896
CPXV_GER2002_MKY Germany, Go ¨ttingen 2002 Fatal generalization marmoset
(Callithrix
jacchus)
Ma ¨tz-Rensing et al. 2006
Vet Pathol 43:212
HQ420898
CPXV_FRA2001_NANCY France, Nancy 2001 Local lesions human HQ420894
CPXV_UK2000_K2984 United Kingdom, Bristol 2000 Local lesions cat HQ420900
CPXV_AUS1999_867 Austria, Texing 1999 Local lesions cat HQ407377
CPXV_GER1980_EP4 Germany, Hameln 1980 Local lesions elephant Pilaski et al. 1986 Arch
Virol 88: 135–142
HQ420895
CPXV_GER1998_2 Germany, Eckental 1998 Local lesions human Pfeffer et al. 1999 BMTW
112:334–338
HQ420897
Information is given for CPXV isolates used in the phylogenetic analysis, including place and date of isolation, clinical information, reference and GenBank accession
number.
doi:10.1371/journal.pone.0023086.t001
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patristic/). For both methods, distances were averaged across taxa
to produce a value at each node. A threshold value was calculated
for both the patristic and genetic distance using the distances
between Taterapox virus (TATV) and Variola virus (VARV). These
values (VARV-TATV) represent the distance between two
currently recognized and undeniably distinct OPV species.
Comparisons were then made between the other OPV species,
including the CPXV isolates, to determine which of these
exceeded the VARV-TATV threshold value.
Results
The CPXV phylogenetic tree presented in Figure 1 depicts two
major OPV clades. One includes three CPXV isolates most closely
related to VACV (sister to MPXV) and the other is monophyletic
(9 CPXV) and sister to VARV, TATV and CMLV. Using the
TATV-VARV threshold (0.0154) as a guide, the CPXV isolates
can be split into two major monophyletic clades (Cowpox-like and
Vaccinia-like) and further into the five distinct monophyletic
clusters. Distance measures for each of these clusters exceed the
TATV-VARV threshold value. Table 1 has detailed information
about the year and source of each isolate depicted on the tree and
Figure 2 shows their geographic distribution. German CPXV
isolates are found in 4 of the 5 groups (groups 1–4) which are all in
the Cowpox-like clade and are the exclusive members of groups 1,
2, and 4. Group 1 is composed of two German isolates. Groups 2
and 3 are distinct sister taxa and are each represented by a single
German CPXV isolate, and isolates from the UK, Norway,
Germany, and France, respectively. Group 4 is a single German
isolate which is sister to the 2–3 cluster. Group 5 is sister to a
MPXV clade and forms the second major clade and consists of the
Vaccinia-like isolates. This is the most speciose CPXV associated
assemblage containing two separate monophyletic CPXV clusters
as well as all of the included smallpox vaccine strains and other
VACV isolates including Buffalopox virus (BPXV), Rabbitpox
virus (RPXV) and Horsepox virus (HPXV). None of the genetic
distances between isolates in group 5 exceeds the distance between
TATV and VARV. When patristic distances are examined, three
additional values exceed the threshold (marked with asterisks in
Fig. 1) distinguishing a total of eight different clusters.
To examine amino acid level properties of the identified CPXV
clades, the coding sequence of three genes randomly selected from
a list of relatively well characterized genes, (CrmC, viroceptor,
Figure 1. CPXV Phylogeny. The tree search was based on a complete coding region alignment (C23L-B29R) with gapped columns removed
(145,177 bp). Posterior probabilities are shown to the right of each node in black. Uncorrected p distance measures were calculated from the matrix
and are shown to the left of each node. Red indicates distances greater than or equal to the distance between TATV and the VARV clade (0.0154);
blue indicates a distance less than this value. Additional distance measures between nodes and taxa are underlined and designated by dashed
arrows. Asterisks indicate distance values at nodes where patristic distance values are above the VARV-TATV threshold and conflict with uncorrected
p values. Cowpox-like (groups 1–4) and Vaccinia-like (group 5) clades are indicated to the right. Brackets encompass isolates or groups of isolates
where distance measures separate them from their nearest neighbours at least as much as the distance between TATV and VARV. Each of these
groups is labelled with a number (1–5).
doi:10.1371/journal.pone.0023086.g001
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IFN a/b receptor homolog [21]; and vaccinia growth factor,
epidermal growth factor-like protein [22]) linked to potential
virulence factors were aligned for all CPXV isolates included in
the phylogenetic analyses (Figure 3). Several unique non-
synonymous mutations were found that unite each of the
previously identified monophyletic lineages (groups 1, 3, and 5).
In addition, group 3 is characterized by a truncation of gene C5L
(unknown function). An image of the aligned CPXV genomes and
their respective open reading frames is available in the online
supporting material, Figure S1.
Discussion
Although previous researchers have recognized that substantial
genotypic and phenotypic diversity exists among CPXV species, to
date no one has objectively analyzed this diversity and put it into a
taxonomic context relevant to the other members of the Genus
Orthopoxvirus. The data herein depicts CPXV as a polyphyletic
assemblage in which one of the major CPXV clades is more
closely related to MPXV and the other is more closely allied to
variola, camel and tatera pox viruses. This would mean that if the
current CPXV taxonomic scheme is to remain an intact
monophyletic clade then, all Orthopoxvirus isolates with the
exception of Ectromelia virus and the new world species, Raccoonpox
virus, Skunkpox virus and Volepox virus, would need to be assigned to
the species Cowpox virus. A more reasonable solution is to rename
the distinct CPXV lineages.
The fact that the traditionally defined CPXV have the largest
genomes has led previous investigators to suggest that a cowpox-
like virus is the ancestor of all OPV species [23]. Furthermore, the
deepest divergence within OPV clades is between the North
American OPV species (Skunkpox, Racoonpox, and Volepox
viruses) and the remainder of the genus, followed by Ectromelia virus
[24]. The deep node from which the New World OPXV species
diverge, along with the results herein suggest that the shared
CPXV phenotypic characteristics such as; large genome size, A
type inclusions, flattened hemorrhagic lesions on CAM, and rabbit
lesion morphology, uniting the traditionally recognized CPXV
isolates, likely represent ancestral characteristics maintained in the
distinct CPXV lineages but lost by other OPV species.
The smallpox vaccine is known to have originated in the United
Kingdom, however the vaccine strains were most closely allied to
CPXV isolates from Russia (CPXV-GRI) and from Finland
(CPXV_Fin2000_Man), with the Austrian isolate (CPXV_AUS
1999_867) joining just outside that sister relationship. This could
be explained by a lack of sufficient UK isolates in our analyses,
which would imply that multiple CPXV and/or VACV genotypes
are circulating in that region that have not yet been identified. The
pairwise identity between the coding regions of CPXV_UK
2000_K2984 and CPXV_BR is 98.4%. These two isolates were
collected 63 years apart, but are both from the southern region of
England and the Bristol isolate is roughly 23 miles from the region
where Jenner’s vaccination work occurred. Thus the genotypes
represented in these analyses should be representative of the
CPXV strains available to Jenner. A more likely scenario is that
Figure 2. Map of CPXV isolate origins. The place of origin for each CPXV isolate is designated on the map. The inset shows CPXV isolates divided
into five distinct clusters corresponding to those in Figure 1 and grouped by dashed lines.
doi:10.1371/journal.pone.0023086.g002
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here) were not made from the original Jenner strain, but instead
from isolates found in other regions of Europe. Taxonomically, the
UK isolates from near the ‘‘type’’ locality (i.e. near Jenner’s
original collection site) have priority to keep the Cowpox virus
designation. In future studies, the inclusion of more sequences
from other circulating vaccinia-like strains would be of evolution-
ary, epidemiological, and taxonomic importance.
The Buffalopox virus and Horsepox virus isolates are imbedded
within the Vaccinia-like clade. There are multiple hypotheses as to
the origin of wild VACV isolates [25]. The two prevailing scenarios
are 1) these isolates represent vaccine derived strains that were
utilized during the smallpox vaccination campaign and subse-
quently escaped and became endemic in these regions or 2) they
are native viruses. The topology displayed here favors the first
scenario (Figure 1). However, the long branch separating
Horsepox virus from other VACV isolates suggests that more
detailed analyses with additional sampling are needed to
successfully resolve this discussion.
Both the historic and current literature describe ‘‘cowpox’’ as a
disease with a single etiologic agent. Further, there has been
confusion over the relationship between the causative agents of
‘‘cowpox’’ and ‘‘horsepox’’, and the transition from what was
historically called ‘‘cowpox’’ to the modern VACV-based vaccine
strains. Much of this confusion results from the practice of naming
agents after the host in which the resultant disease manifests. Using
the TATV-VARV genetic distance threshold, CPXV isolates
could be split into as many as five distinct monophyletic lineages.
This threshold is likely conservative and is higher than the value
seen between TATV and CMLV, two commonly accepted distinct
OPXV species. If the lower TATV-CMLV threshold is used then
Austrian, Norwegian, and British isolates are also distinct. This
latter scenario would taxonomically differentiate the most
geographically distinct isolates. The nucleotide data in Figure 1
and the coding data in Figure 3 support the elevation of up to four
new species designations within the traditional CPXV group.
According to taxonomic priority our clade 3 (Figures 1&2) would
maintain the designation Cowpox virus since it contains isolates from
the United Kingdom closest to the type locality from which the
original CPXV isolates were described. If the taxonomic changes
proposed herein are correct then it is likely that yet to be
discovered biological similarities exist which unite the depicted
clades/species. We chose to examine three genes that have been
relatively well characterized in previous studies, for evidence of
amino acid level changes which unite the proposed clades and
found supporting data in all three loci. The nonsynonymous
Figure 3. Alignment of three CPXV genes. Alignment images were created in Geneious Pro
TM 5.3. Isolate names are provided to the right along
with the branching relationships and numbered groups presented in Figure 1. Sequence areas depicted were extracted from the following coding
regions: (A) CPXV_BR_021 (VACV_COP_C11R), secreted virulence factor, vaccinia growth factor (VGF; epidermal growth factor-like protein), promotes
cell survival; (B) CPXV_BR_191 (VACV_COP_A53R), CrmC, viroceptor, soluble virus tumor necrosis factor receptor homolog, binds and antagonizes
TNF-a; (C) CPXV_BR_212 (VACV_COP_B19R), viroceptor, soluble IFN a/b receptor homolog, binds and antagonizes IFN a/b. Numbers along the top of
the alignment refer to the position of the region in the full genome alignment (supplementary material). Grey indicates conserved bases while colors
(red, blue, yellow, green) indicate differences (A, C, G, T, respectively) with regard to the reference sequence (CPXV_GER1980_EP4) highlighted in
yellow. Colored boxes identify shared nucleotide states that reflect monophyletic relationships seen in the tree. Notations below each alignment
describe subsequent amino acid changes (standard IUPAC code).
doi:10.1371/journal.pone.0023086.g003
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soluble virus tumor necrosis factor receptor homolog [20]; soluble
IFN a/b receptor homolog [21]; and vaccinia growth factor,
epidermal growth factor-like protein [22] indicate that there are
likely common protein structures shared within members of clades
1, 3 and 5 which could impact virulence and/or host range, thus
supporting their recognition as distinct lineages. Furthermore, all
members of clade 3 share a truncated C5L gene. We anticipate
that future studies will reveal many other unique biological
properties within each of the clades identified by this research
effort.
In the most conservative view, our results show that CPXV
strains group into at least two separate strongly supported and
deeply divided clades. One clade includes VACV strains (both
wild and laboratory propagated) while the other includes only
strains previously identified as CPXV. This is congruent with
previous observations differentiating CPXV Brighton Red and
Grishak into two species [15]. Additional virological character-
ization is needed to specifically examine and subsequently assign
these clades to the correct taxonomic category, however, all
scenarios described herein suggest that a re-classification of CPXV
strains is clearly warranted. Historic literature states that the
original vaccine strains were derived from ‘‘cowpox’’ samples [2].
Additionally, the phylogeny presented here suggests the progenitor
of the modern smallpox vaccine likely lies in mainland Europe and
not the UK.
Supporting Information
Figure S1 Image of twelve CPXV genomes created in Geneious
Pro
TM 5.3. The alignment was created using the MAFFT plugin.
Orange arrows indicate coding regions in both directions. Bases
are numbered at the top of the alignment and strain names
indicated to the left. The reference genome, CPXV_GER1980
_EP4, is highlighted in yellow. In subsequent genomes, grey
indicates identity and vertical black lines represent differences with
respect to the reference sequence.
(TIF)
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